
Lakewood-Amedex Biotherapeutics Inc (LABT)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy LABT Stock
Start investing in LABT
About Lakewood-Amedex Biotherapeutics Inc (LABT)
| Market cap | $5.31M |
| Friday's volume | 70.56K |
| Revenue (TTM) | — |
| Avg. daily volume | 1.48M |
| EBITDA (TTM) | -$7.15M |
| Open | $2.18 |
| Price / earnings ratio | -0.22x |
| Friday's range | $2.17 - $2.34 |
| Debt / equity | 0.02x |
| 52 week range | $1.66 - $98.2 |
| 5 year debt / equity | 0.14x |
| Beta (LTM) | 0.17x |
| Interest coverage | -37.39x |
| Dividend & yield | $0.00 (0.00%) |
| Current ratio | 7.7x |
| Ex-dividend date | |
| Next earnings | |
| Dividend payable date |
LABT Stock News




Frequently Asked Questions (FAQ)
How to buy LABT stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in LABT stock
Navigate to the Explore page. Then, type LABT into the search bar. When you see LABT stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased LABT stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.
Lakewood-Amedex Biotherapeutics Inc Stock Earnings
The value each LABT share was expected to gain vs. the value that each LABT share actually gained.
LABT (LABT) reported earnings per share (EPS) of $0, — estimates of $0 by —. In the same quarter last year, LABT's earnings per share (EPS) was $0. LABT is expected to release next earnings on , with an earnings per share (EPS) estimate of -$0.34.